Sight Sciences, Inc.
SGHT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.18 | 0.25 | -0.10 | -0.86 |
| FCF Yield | -4.93% | -3.62% | -9.43% | -1.94% |
| EV / EBITDA | -18.79 | -14.59 | -4.31 | -10.02 |
| Quality | ||||
| ROIC | -7.46% | -10.55% | -11.73% | -9.33% |
| Gross Margin | 86.39% | 84.78% | 86.21% | 86.82% |
| Cash Conversion Ratio | 1.07 | 0.63 | 0.82 | 0.29 |
| Growth | ||||
| Revenue 3-Year CAGR | -2.81% | -2.18% | 1.24% | 3.84% |
| Free Cash Flow Growth | -14.65% | 33.19% | -222.72% | -755.01% |
| Safety | ||||
| Net Debt / EBITDA | 7.56 | 5.81 | 5.38 | 7.64 |
| Interest Coverage | -6.05 | -9.09 | -10.97 | -10.27 |
| Efficiency | ||||
| Inventory Turnover | 0.34 | 0.48 | 0.42 | 0.40 |
| Cash Conversion Cycle | 251.43 | 169.33 | 161.78 | 216.85 |